N-(4-amino-2-methylquinolin-6-yl)-2-[(4-ethylphenoxy)methyl]benzamide;hydrochloride


Chemical Name: N-(4-amino-2-methylquinolin-6-yl)-2-[(4-ethylphenoxy)methyl]benzamide;hydrochloride
CAS Number: 244218-51-7
Product Number: AG00BF3X(AGN-PC-0LPWG1)
Synonyms:
MDL No: MFCD06198707
Molecular Formula: C26H26ClN3O2
Molecular Weight: 447.9565

Identification/Properties


Computed Properties
Molecular Weight:
447.963g/mol
Hydrogen Bond Donor Count:
3
Hydrogen Bond Acceptor Count:
4
Rotatable Bond Count:
6
Exact Mass:
447.171g/mol
Monoisotopic Mass:
447.171g/mol
Topological Polar Surface Area:
77.2A^2
Heavy Atom Count:
32
Formal Charge:
0
Complexity:
577
Isotope Atom Count:
0
Defined Atom Stereocenter Count:
0
Undefined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Covalently-Bonded Unit Count:
2
Compound Is Canonicalized:
Yes

Safety Information


GHS Pictogram:
Signal Word:
Warning
UN#:
-
Hazard Statements:
H319-H413
Precautionary Statements:
P305+P351+P338
Class:
-
Packing Group:
-

NMR Spectrum


Other Analytical Data


Request for Quotation


Customer Feedback


Chemical Structure



JTC-801 is a potent and selective antagonist of the nociceptin/orphanin FQ peptide (NOP) receptor, which plays a crucial role in pain modulation and addiction pathways. In chemical synthesis, this compound is utilized as a valuable tool to investigate the pharmacological effects and mechanisms associated with the NOP receptor. By effectively blocking the action of the NOP receptor, JTC-801 can help researchers gain a deeper understanding of the signaling pathways involved in pain perception and addictive behaviors. Additionally, JTC-801 can be employed in studies aiming to develop novel therapeutics for conditions such as chronic pain, drug dependence, and mood disorders, by providing insights into the physiological functions of the NOP receptor. Its application in chemical synthesis offers a powerful approach to elucidate the complex interplay between the NOP receptor and various physiological processes, paving the way for potential therapeutic interventions targeting this important signaling pathway.